TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34873674

Group type: EXPERIMENTAL
Intervention: GSK2256294 (10 mg once daily for 10 days)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: GSK2256294
Number of subjects: 19
Study: 33677694

Group type: EXPERIMENTAL
Intervention: Strength Training Group (STG)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Functional Strength Training Group (FTG)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Young Group (Y)
Number of subjects: 38
Study: 32106075

Group type: EXPERIMENTAL
Intervention: External Counterpulsation (ECP)
Number of subjects: 13
Study: 34985184

Group type: EXPERIMENTAL
Intervention: Moderate-intensity cycling exercise (6 minutes)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Constant power output exercise bouts to task failure (TTF) at varying intensities (15% below MLSS, 10 W below MLSS, MLSS, 10 W above MLSS)
Number of subjects: 16
Study: 33779520

Group type: EXPERIMENTAL
Intervention: Media Aware (web-based SHE program)
Number of subjects: 331
Study: 35830070

Group type: EXPERIMENTAL
Intervention: Mycorrhizal inoculants associated with Bradyrhizobium BR3267 strain
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Acaulospora longula treatments
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: G. albida + Bradyrhizobium BR 3267
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: A. longula
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (reference)
Number of subjects: 5
Study: 33528904

Group type: EXPERIMENTAL
Intervention: Empagliflozin (25 mg/day) with no meal announcement
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Empagliflozin (25 mg/day) with simple meal announcement
Number of subjects: 30

Group type: COMPARATOR
Intervention: Carbohydrate counting without empagliflozin (control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Empagliflozin with carbohydrate counting
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 30
Study: 32742512

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral counseling (8 sessions, 60-90 minutes each)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (routine pregnancy care)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral counseling
Number of subjects: 70
Study: 35961948

Group type: EXPERIMENTAL
Intervention: Bevacizumab biosimilar
Number of subjects: 98

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 98
Study: 34959773

Group type: EXPERIMENTAL
Intervention: EMG of the corrugator supercilii muscles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EMG of the masseter and suprahyoid muscles
Number of subjects: 0
Study: 34870133

Group type: EXPERIMENTAL
Intervention: SII-ChAdOx1 nCoV-19
Number of subjects: 1601
Study: 32387298

Group type: EXPERIMENTAL
Intervention: General health, lifestyle and sexual behavior factors
Number of subjects: 14271

Group type: EXPERIMENTAL
Intervention: Overweight
Number of subjects: 14271

Group type: EXPERIMENTAL
Intervention: Obese
Number of subjects: 14271

Group type: EXPERIMENTAL
Intervention: Perceived themselves as much too fat
Number of subjects: 14271

Group type: EXPERIMENTAL
Intervention: Poor self-perceived health
Number of subjects: 14271

Group type: EXPERIMENTAL
Intervention: Daily smoking
Number of subjects: 14271

Group type: EXPERIMENTAL
Intervention: Previous genital warts or other sexually transmitted infections
Number of subjects: 14271

Group type: EXPERIMENTAL
Intervention: Young women with ≥10 lifetime sexual partners or ≥2 new recent partners
Number of subjects: 14271
Study: 34493393

Group type: EXPERIMENTAL
Intervention: Health Star Rating
Number of subjects: 3584

Group type: COMPARATOR
Intervention: High in labels
Number of subjects: 3584

Group type: COMPARATOR
Intervention: Multiple traffic light
Number of subjects: 3584
Study: 33372118

Group type: EXPERIMENTAL
Intervention: Recipe 4 Success
Number of subjects: 73

Group type: COMPARATOR
Intervention: Usual practice Early Head Start
Number of subjects: 73
Study: 32376293

Group type: EXPERIMENTAL
Intervention: Automated Pcuff correction (combined with manual correction)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual Pcuff correction alone
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 36483239

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA) combined with physical exercise for 2 weeks with a 26-week follow-up.
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group with no EA intervention.
Number of subjects: 110
Study: 32272776

Group type: EXPERIMENTAL
Intervention: Online hemodiafiltration (HDF)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Low-flux hemodialysis (HD)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Residual kidney function (RKF)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: PBUT plasma concentrations
Number of subjects: 80
Study: 33516240

Group type: EXPERIMENTAL
Intervention: Tai Chi training for 12 weeks, 36 sessions of 60 minutes each
Number of subjects: 64

Group type: COMPARATOR
Intervention: Waiting list group maintaining routine lifestyle
Number of subjects: 64
Study: 36111386

Group type: EXPERIMENTAL
Intervention: Supervised therapeutic exercise intervention (tailored multicomponent exercise program for 8 weeks, two supervised sessions per week with resistance and aerobic training, plus a third day of monitored light intensity continuous training)
Number of subjects: 39

Group type: COMPARATOR
Intervention: WHO rehabilitation guidelines (control group)
Number of subjects: 39
Study: 34823467

Group type: EXPERIMENTAL
Intervention: Eptinezumab 100 mg, 300 mg, 1000 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32713463

Group type: EXPERIMENTAL
Intervention: Surgical release by a posterior approach without triceps detachment, followed by a rehabilitation protocol similar to the conservative group.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rehabilitation protocol associated with the use of orthoses (static progressive for extension and dynamic for flexion) and continuous passive motion.
Number of subjects: 30
Study: 35490438

Group type: EXPERIMENTAL
Intervention: Two nights of restricted four-hour sleep
Number of subjects: 46

Group type: COMPARATOR
Intervention: Two nights of habitual eight-hour sleep
Number of subjects: 46
Study: 34981490

Group type: EXPERIMENTAL
Intervention: Lentil group (500 mg of lentil powder daily for 3 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo group (placebo daily for 3 months)
Number of subjects: 60
Study: 35190087

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided percutaneous drainage
Number of subjects: 128

Group type: COMPARATOR
Intervention: Surgical drainage
Number of subjects: 128
Study: 33680304

Group type: EXPERIMENTAL
Intervention: Personal HUDs (n = 24) for patient care/self‐directed learning
Number of subjects: 47

Group type: COMPARATOR
Intervention: No HUDs (n = 23)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Personal HUDs (n = 24)
Number of subjects: 47
Study: 32503494

Group type: EXPERIMENTAL
Intervention: Trimetazidine (35 mg twice a day)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 35729250

Group type: EXPERIMENTAL
Intervention: L-menthol (n=26)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (n=26)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: L-menthol
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 34250817

Group type: EXPERIMENTAL
Intervention: Liraglutide (glucagon-like peptide-1 receptor agonist)
Number of subjects: 50
Study: 32073934

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (no SSC)
Number of subjects: 128
Study: 36036907

Group type: EXPERIMENTAL
Intervention: Lumbar epidural steroid injections (LESIs)
Number of subjects: 3259

Group type: COMPARATOR
Intervention: Control treatment in the RCT of LESI
Number of subjects: 3259
Study: 35866910

Group type: EXPERIMENTAL
Intervention: Baricitinib in combination with topical corticosteroids
Number of subjects: 0
Study: 33200220

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg monotherapy
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg (+MTX)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo (+MTX) switched to Baricitinib 4 mg (+MTX)
Number of subjects: 148
Study: 34330756

Group type: COMPARATOR
Intervention: Anterior‐posterior 12.5% depth
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Anterior‐posterior 25% depth
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Anterior‐posterior 33% depth
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Anterior‐posterior 40% depth
Number of subjects: 32
Study: 32811629

Group type: EXPERIMENTAL
Intervention: Take-home naloxone (THN) administration with positive communication
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Take-home naloxone (THN) administration with negative communication
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Withdrawal symptoms
Number of subjects: 47
Study: 36141823

Group type: EXPERIMENTAL
Intervention: Freediving training + Pulmonary Rehabilitation (FD + PR)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Pulmonary Rehabilitation (PR)
Number of subjects: 69
Study: 33812910

Group type: COMPARATOR
Intervention: 3% Hypertonic Saline (HTS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Desmopressin (D-HTS) in addition to 3% Hypertonic Saline
Number of subjects: 0
Study: 35420844

Group type: EXPERIMENTAL
Intervention: Self-directed mindfulness training
Number of subjects: 127

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 127
Study: 33906847

Group type: EXPERIMENTAL
Intervention: CHW
Number of subjects: 593

Group type: EXPERIMENTAL
Intervention: CHW+CCT
Number of subjects: 593

Group type: COMPARATOR
Intervention: Control
Number of subjects: 593
Study: 32822650

Group type: EXPERIMENTAL
Intervention: Indwelling catheterization
Number of subjects: 252

Group type: COMPARATOR
Intervention: Intermittent catheterization (every 2 hours)
Number of subjects: 252
Study: 34654643

Group type: EXPERIMENTAL
Intervention: Fentanyl (FENTA)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fentanyl plus glycopyrrolate (FENTAglyco)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fentanyl (FENTA) with prevention of bradycardia
Number of subjects: 6
Study: 34431970

Group type: EXPERIMENTAL
Intervention: IL-6 levels ≥2.0 ng/L
Number of subjects: 14611
Study: 33739848

Group type: COMPARATOR
Intervention: RT (Radiotherapy)
Number of subjects: 2014

Group type: EXPERIMENTAL
Intervention: RT plus T (Radiotherapy plus Trastuzumab)
Number of subjects: 2014
Study: 32846762

Group type: EXPERIMENTAL
Intervention: CBT-Music intervention program
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study: 36308628

Group type: EXPERIMENTAL
Intervention: Effective Communication within the Organization (ECO) program
Number of subjects: 191

Group type: COMPARATOR
Intervention: Psychoeducative lectures (PE) about pain and stress
Number of subjects: 191
Study: 33053258

Group type: EXPERIMENTAL
Intervention: Action-Based Cognitive Remediation (ABCR)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 61
Study: 32492705

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) - 10×1-minute at 90%HRmax, 1-minute active recovery (n=16)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT) - 45 minutes at 70%HRmax (n=15)
Number of subjects: 31
Study: 33867420

Group type: EXPERIMENTAL
Intervention: Probucol
Number of subjects: 1025

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1025
Study: 32749173

Group type: EXPERIMENTAL
Intervention: Oral EGCG 100 mg twice daily for 10 days
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 36127760

Group type: EXPERIMENTAL
Intervention: Multicomponent case management intervention (4-month duration, including two home or clinic visits and two telephone interviews)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Multicomponent case management intervention
Number of subjects: 76

Group type: COMPARATOR
Intervention: Routine care and two social phone calls (control group)
Number of subjects: 76
Study: 33629114

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (AIs) adherence
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Younger patients (younger than age 65 years)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Composite risk model based on baseline PRO scales
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Highest-risk patients
Number of subjects: 702
Study: 33262578

Group type: EXPERIMENTAL
Intervention: Evogliptin 5 mg alone (EVO)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Glimepiride 4 mg alone (GLI)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Combination of evogliptin and glimepiride (EVO+GLI)
Number of subjects: 34
Study: 35622848

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) as an adjunct to standard of care with medical oxygen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care with medical oxygen
Number of subjects: 0
Study: 34459744

Group type: EXPERIMENTAL
Intervention: Web-based video 'Mon Coeur, Mon BASIC' and a short interview with the pharmacist
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Web-based video 'Mon Coeur, Mon BASIC'
Number of subjects: 60
Study: 32106619

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 36425572

Group type: EXPERIMENTAL
Intervention: PMA-ZEO
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 34024187

Group type: EXPERIMENTAL
Intervention: Iodine excretion level in urine among school-aged children
Number of subjects: 1455

Group type: EXPERIMENTAL
Intervention: Iodine excretion level in urine among pregnant women
Number of subjects: 1455
Study: 36153475

Group type: EXPERIMENTAL
Intervention: Itacitinib (a selective JAK1 inhibitor) combined with ASTX727 (a fixed dose oral combination of decitabine and cedazuridine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 34698724

Group type: EXPERIMENTAL
Intervention: Individualized CAD/CAM healing abutments
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional healing abutments
Number of subjects: 20
Study: 32244424

Group type: EXPERIMENTAL
Intervention: Double-Taped Kinesio Taping (DTKT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Normal-Tape Kinesio Taping (NTKT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 33556804

Group type: EXPERIMENTAL
Intervention: Oseltamivir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zanamivir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laninamivir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peramivir
Number of subjects: 0
Study: 33920935

Group type: EXPERIMENTAL
Intervention: Resistance training (EG1)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Aerobic training (EG2)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 113
Study: 34627832

Group type: EXPERIMENTAL
Intervention: Serratus anterior plane block (SAPB) with 0.4 mL.kg-1 0.5% ropivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Thoracic paravertebral block (TPVB)
Number of subjects: 40
Study: 32359776

Group type: EXPERIMENTAL
Intervention: 10 mg intravenous metoclopramide
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 50 mg intravenous dexketoprofen trometamol
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 50 mg dexketoprofen trometamol + 10 mg metoclopramide
Number of subjects: 150
Study: 34796658

Group type: EXPERIMENTAL
Intervention: Brief CBT-based telephone counseling
Number of subjects: 2628
Study: 32131911

Group type: EXPERIMENTAL
Intervention: CORDIAL program (11 individual weekly sessions of CBT, cognitive rehabilitation, and reminiscence therapy)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Treatment-as-usual (Control group)
Number of subjects: 198
Study: 35691664

Group type: EXPERIMENTAL
Intervention: Tinzaparin
Number of subjects: 301
Study: 34636493

Group type: EXPERIMENTAL
Intervention: Q-switched Nd:YAG laser with daily 3% tranexamic acid gel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Microneedling with daily 3% tranexamic acid gel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 60
Study: 33189627

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 27918

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 27918

Group type: EXPERIMENTAL
Intervention: Lisinopril (in participants with diabetes)
Number of subjects: 27918

Group type: EXPERIMENTAL
Intervention: Lisinopril (in diabetes-free participants)
Number of subjects: 27918
Study: 34706816

Group type: EXPERIMENTAL
Intervention: Preoperative MRI
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Younger patients with invasive lobular tumors
Number of subjects: 396

Group type: COMPARATOR
Intervention: Female surgeons
Number of subjects: 396

Group type: COMPARATOR
Intervention: Surgeons in community practice
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Time period of the study
Number of subjects: 396
Study: 33122573

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Midazolam (MDZ)
Number of subjects: 102
Study: 32727548

Group type: EXPERIMENTAL
Intervention: Simparica Trio® (combination of sarolaner, moxidectin, and pyrantel)
Number of subjects: 622

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 622

Group type: EXPERIMENTAL
Intervention: Survey study
Number of subjects: 622
Study: 34971551

Group type: EXPERIMENTAL
Intervention: KUR-113 (0.4 mg/mL)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: KUR-113 (0.133 mg/mL)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: KUR-113 (1.0 mg/mL)
Number of subjects: 200
Study: 32168551

Group type: EXPERIMENTAL
Intervention: Palonosetron 0.75 mg (day 1) combined with dexamethasone and fosaprepitant
Number of subjects: 326

Group type: COMPARATOR
Intervention: Granisetron 1 mg (day 1) combined with dexamethasone and fosaprepitant
Number of subjects: 326
Study: 36386031

Group type: EXPERIMENTAL
Intervention: Automated case investigation and contact tracing (CICT)
Number of subjects: 106522

Group type: COMPARATOR
Intervention: Manual case investigation and contact tracing (CICT)
Number of subjects: 106522
Study: 33640345

Group type: EXPERIMENTAL
Intervention: Remote Patient Monitoring (RPM)
Number of subjects: 1450

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 1450

Group type: EXPERIMENTAL
Intervention: Alert driven
Number of subjects: 1450
Study: 35104166

Group type: EXPERIMENTAL
Intervention: Insulin pump infusion sets (various types)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Insulin pump infusion sets (90° Teflon)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Insulin pump infusion sets (angled Teflon)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Insulin pump infusion sets (steel)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Age groups (youth vs adults)
Number of subjects: 263
Study: 33219706

Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (CIMT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 21
Study: 35428722

Group type: EXPERIMENTAL
Intervention: SEC 300 mg
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: SEC 150 mg
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study: 34180209

Group type: EXPERIMENTAL
Intervention: Triclosan coated Vicryl 2/0 suture
Number of subjects: 49

Group type: COMPARATOR
Intervention: Intravenous antibiotics
Number of subjects: 49
Study: 32199095

Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m2 administered intravenously every week for 4 weeks, then 1000 mg every 2 weeks at 24 weeks and 48 weeks after randomisation)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (matching intravenous administration)
Number of subjects: 38
Study: 35457289

Group type: EXPERIMENTAL
Intervention: Exercise breaks (5 × 6 min cycling at 70% VO2 max)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Single bout of exercise (30 min cycling at 70% VO2 max)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control condition (sitting)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Exercise breaks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both exercise trials
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Exercise prior to sitting
Number of subjects: 18
Study: 32673049

Group type: EXPERIMENTAL
Intervention: Fixed price sequence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized price sequence
Number of subjects: 0
Study: 33007527

Group type: EXPERIMENTAL
Intervention: pQCT assessment at 12 months
Number of subjects: 1639

Group type: EXPERIMENTAL
Intervention: pQCT assessment at 24 months
Number of subjects: 1639

Group type: EXPERIMENTAL
Intervention: Comparison of bone parameters between 12 and 24 months
Number of subjects: 1639

Group type: EXPERIMENTAL
Intervention: Adjustment of bone parameters for weight, length, and scan quality
Number of subjects: 1639
Study: 35409619

Group type: EXPERIMENTAL
Intervention: 30‐min structured protocol of nature contact
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 33259968

Group type: EXPERIMENTAL
Intervention: PMMA-augmented screws
Number of subjects: 50

Group type: COMPARATOR
Intervention: Uncemented screws (Control)
Number of subjects: 50
Study: 32203065

Group type: EXPERIMENTAL
Intervention: Midodrine (10 mg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 41
Study: 35527576

Group type: EXPERIMENTAL
Intervention: Intensive computer-based cognitive program using REHACOM software in addition to conventional physical therapy (aerobic training, resistive training, flexibility program)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional physical therapy program for MS including aerobic training, resistive training, flexibility program and placebo cognitive sessions
Number of subjects: 40
Study: 33001537

Group type: EXPERIMENTAL
Intervention: Intralesional corticosteroids (ILCs)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Topical TCA 35%
Number of subjects: 22